Skip to main content
Erschienen in: Tumor Biology 8/2014

01.08.2014 | Research Article

HIFs enhance the migratory and neoplastic capacities of hepatocellular carcinoma cells by promoting EMT

verfasst von: Yang Liu, Yawei Liu, Xiaolu Yan, Yuan Xu, Fei Luo, Jing Ye, Han Yan, Xiaojun Yang, Xiaodan Huang, Jianping Zhang, Guozhong Ji

Erschienen in: Tumor Biology | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Hepatocellular carcinoma (HCC) is one of the most fatal cancers. Although the involvement of the epithelial-to-mesenchymal transition (EMT) in HCC progression is established, the mechanisms modulating this phenomenon remain unclear. Here, we demonstrate that hypoxia-inducible factors (HIFs), HIF-1α and HIF-2α, modulate the EMT through Twist1, a regulator of the EMT. The levels of HIF-1α and HIF-2α in HCC tissues were higher than those in matched, non-tumor surrounding tissues. In HCC samples, the levels of HIF-1α and HIF-2α negatively correlated with the levels of E-cadherin but positively correlated with the levels of vimentin. In highly metastatic MHCC97H cells, the levels of HIF-1α, HIF-2α, and Twist1 were higher than those in weakly metastatic HepG2 cells. In HepG2 cells, over-expression of HIFs enhanced levels of Twist1 and the EMT, which elevated the migratory and neoplastic capacities of cells. For MHCC97H cells, inhibition of HIFs reduced Twist1 levels and the EMT, which reduced their migratory and neoplastic capacity. Thus, the promotion of EMT by HIFs via Twist1 enhanced the migration and neoplastic capacities of HCC cells.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: Cancer J Clin. 2011;61:69–90. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: Cancer J Clin. 2011;61:69–90.
2.
Zurück zum Zitat Stebbing J, Filipovic A, Giamas G. Claudin-1 as a promoter of emt in hepatocellular carcinoma. Oncogene. 2013;32:4871–2.PubMedCrossRef Stebbing J, Filipovic A, Giamas G. Claudin-1 as a promoter of emt in hepatocellular carcinoma. Oncogene. 2013;32:4871–2.PubMedCrossRef
3.
Zurück zum Zitat van Zijl F, Zulehner G, Petz M, Schneller D, Kornauth C, Hau M, et al. Epithelial–mesenchymal transition in hepatocellular carcinoma. Future Oncol. 2009;5:1169–79.PubMedCrossRef van Zijl F, Zulehner G, Petz M, Schneller D, Kornauth C, Hau M, et al. Epithelial–mesenchymal transition in hepatocellular carcinoma. Future Oncol. 2009;5:1169–79.PubMedCrossRef
4.
Zurück zum Zitat Jiang J, Tang YL, Liang XH. Emt: A new vision of hypoxia promoting cancer progression. Cancer Biol Ther. 2011;11:714–23.PubMedCrossRef Jiang J, Tang YL, Liang XH. Emt: A new vision of hypoxia promoting cancer progression. Cancer Biol Ther. 2011;11:714–23.PubMedCrossRef
5.
Zurück zum Zitat Ogunwobi OO, Liu C. Therapeutic and prognostic importance of epithelial-mesenchymal transition in liver cancers: insights from experimental models. Crit Rev Oncol Hematol. 2012;83:319–28.PubMedCrossRef Ogunwobi OO, Liu C. Therapeutic and prognostic importance of epithelial-mesenchymal transition in liver cancers: insights from experimental models. Crit Rev Oncol Hematol. 2012;83:319–28.PubMedCrossRef
6.
Zurück zum Zitat Naber HP, Drabsch Y, Snaar-Jagalska BE, ten Dijke P, van Laar T. Snail and slug, key regulators of tgf-beta-induced emt, are sufficient for the induction of single-cell invasion. Biochem Biophys Res Commun. 2013;435:58–63.PubMedCrossRef Naber HP, Drabsch Y, Snaar-Jagalska BE, ten Dijke P, van Laar T. Snail and slug, key regulators of tgf-beta-induced emt, are sufficient for the induction of single-cell invasion. Biochem Biophys Res Commun. 2013;435:58–63.PubMedCrossRef
8.
Zurück zum Zitat Tang O, Chen XM, Shen S, Hahn M, Pollock CA. Mirna-200b represses transforming growth factor-beta1-induced emt and fibronectin expression in kidney proximal tubular cells. Am J Physiol Ren Physiol. 2013;304:F1266–73.CrossRef Tang O, Chen XM, Shen S, Hahn M, Pollock CA. Mirna-200b represses transforming growth factor-beta1-induced emt and fibronectin expression in kidney proximal tubular cells. Am J Physiol Ren Physiol. 2013;304:F1266–73.CrossRef
9.
Zurück zum Zitat Thiery JP, Sleeman JP. Complex networks orchestrate epithelial–mesenchymal transitions. Nat Rev Mol Cell Biol. 2006;7:131–42.PubMedCrossRef Thiery JP, Sleeman JP. Complex networks orchestrate epithelial–mesenchymal transitions. Nat Rev Mol Cell Biol. 2006;7:131–42.PubMedCrossRef
10.
Zurück zum Zitat Zhang L, Huang G, Li X, Zhang Y, Jiang Y, Shen J, et al. Hypoxia induces epithelial–mesenchymal transition via activation of snai1 by hypoxia-inducible factor-1alpha in hepatocellular carcinoma. BMC Cancer. 2013;13:108.PubMedCentralPubMedCrossRef Zhang L, Huang G, Li X, Zhang Y, Jiang Y, Shen J, et al. Hypoxia induces epithelial–mesenchymal transition via activation of snai1 by hypoxia-inducible factor-1alpha in hepatocellular carcinoma. BMC Cancer. 2013;13:108.PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Jiao M, Nan KJ. Activation of pi3 kinase/akt/hif-1alpha pathway contributes to hypoxia-induced epithelial–mesenchymal transition and chemoresistance in hepatocellular carcinoma. Int J Oncol. 2012;40:461–8.PubMed Jiao M, Nan KJ. Activation of pi3 kinase/akt/hif-1alpha pathway contributes to hypoxia-induced epithelial–mesenchymal transition and chemoresistance in hepatocellular carcinoma. Int J Oncol. 2012;40:461–8.PubMed
12.
Zurück zum Zitat Bangoura G, Yang LY, Huang GW, Wang W. Expression of hif-2alpha/epas1 in hepatocellular carcinoma. World J Gastroenterol: WJG. 2004;10:525–30.PubMed Bangoura G, Yang LY, Huang GW, Wang W. Expression of hif-2alpha/epas1 in hepatocellular carcinoma. World J Gastroenterol: WJG. 2004;10:525–30.PubMed
13.
Zurück zum Zitat Cane G, Ginouves A, Marchetti S, Busca R, Pouyssegur J, Berra E, et al. Hif-1alpha mediates the induction of il-8 and vegf expression on infection with afa/dr diffusely adhering E. coli and promotes emt-like behaviour. Cell Microbiol. 2010;12:640–53.PubMedCrossRef Cane G, Ginouves A, Marchetti S, Busca R, Pouyssegur J, Berra E, et al. Hif-1alpha mediates the induction of il-8 and vegf expression on infection with afa/dr diffusely adhering E. coli and promotes emt-like behaviour. Cell Microbiol. 2010;12:640–53.PubMedCrossRef
14.
Zurück zum Zitat Moen I, Oyan AM, Kalland KH, Tronstad KJ, Akslen LA, Chekenya M, et al. Hyperoxic treatment induces mesenchymal-to-epithelial transition in a rat adenocarcinoma model. PLoS One. 2009;4:e6381.PubMedCentralPubMedCrossRef Moen I, Oyan AM, Kalland KH, Tronstad KJ, Akslen LA, Chekenya M, et al. Hyperoxic treatment induces mesenchymal-to-epithelial transition in a rat adenocarcinoma model. PLoS One. 2009;4:e6381.PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Xu Y, Li Y, Pang Y, Ling M, Shen L, Yang X, et al. Emt and stem cell-like properties associated with hif-2alpha are involved in arsenite-induced transformation of human bronchial epithelial cells. PLoS One. 2012;7:e37765.PubMedCentralPubMedCrossRef Xu Y, Li Y, Pang Y, Ling M, Shen L, Yang X, et al. Emt and stem cell-like properties associated with hif-2alpha are involved in arsenite-induced transformation of human bronchial epithelial cells. PLoS One. 2012;7:e37765.PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Wang XQ, Zhang W, Lui EL, Zhu Y, Lu P, Yu X, et al. Notch1-snail1-e-cadherin pathway in metastatic hepatocellular carcinoma. Int J Cancer J Int Cancer. 2012;131:E163–72.CrossRef Wang XQ, Zhang W, Lui EL, Zhu Y, Lu P, Yu X, et al. Notch1-snail1-e-cadherin pathway in metastatic hepatocellular carcinoma. Int J Cancer J Int Cancer. 2012;131:E163–72.CrossRef
17.
Zurück zum Zitat Ding SJ, Li Y, Shao XX, Zhou H, Zeng R, Tang ZY, et al. Proteome analysis of hepatocellular carcinoma cell strains, mhcc97-h and mhcc97-l, with different metastasis potentials. Proteomics. 2004;4:982–94.PubMedCrossRef Ding SJ, Li Y, Shao XX, Zhou H, Zeng R, Tang ZY, et al. Proteome analysis of hepatocellular carcinoma cell strains, mhcc97-h and mhcc97-l, with different metastasis potentials. Proteomics. 2004;4:982–94.PubMedCrossRef
18.
Zurück zum Zitat Xu Y, Li Y, Pang Y, Ling M, Shen L, Jiang R, et al. Blockade of p53 by hif-2alpha, but not hif-1alpha, is involved in arsenite-induced malignant transformation of human bronchial epithelial cells. Arch Toxicol. 2012;86:947–59.PubMedCrossRef Xu Y, Li Y, Pang Y, Ling M, Shen L, Jiang R, et al. Blockade of p53 by hif-2alpha, but not hif-1alpha, is involved in arsenite-induced malignant transformation of human bronchial epithelial cells. Arch Toxicol. 2012;86:947–59.PubMedCrossRef
19.
Zurück zum Zitat Xu Y, Li Y, Li H, Pang Y, Zhao Y, Jiang R, et al. The accumulations of hif-1alpha and hif-2alpha by jnk and erk are involved in biphasic effects induced by different levels of arsenite in human bronchial epithelial cells. Toxicol Appl Pharmacol. 2012;266:187–97.PubMedCrossRef Xu Y, Li Y, Li H, Pang Y, Zhao Y, Jiang R, et al. The accumulations of hif-1alpha and hif-2alpha by jnk and erk are involved in biphasic effects induced by different levels of arsenite in human bronchial epithelial cells. Toxicol Appl Pharmacol. 2012;266:187–97.PubMedCrossRef
20.
Zurück zum Zitat Yan H, Dong X, Zhong X, Ye J, Zhou Y, Yang X, Shen J, Zhang J. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in mir-148a-mediated anti-metastasis of hepatocellular carcinoma. Molecular Carcinogenesis. 2013. Yan H, Dong X, Zhong X, Ye J, Zhou Y, Yang X, Shen J, Zhang J. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in mir-148a-mediated anti-metastasis of hepatocellular carcinoma. Molecular Carcinogenesis. 2013.
21.
Zurück zum Zitat Xiang ZL, Zeng ZC, Fan J, Tang ZY, He J, Zeng HY, et al. The expression of hif-1alpha in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome. Mol Biol Rep. 2012;39:2021–9.PubMedCrossRef Xiang ZL, Zeng ZC, Fan J, Tang ZY, He J, Zeng HY, et al. The expression of hif-1alpha in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome. Mol Biol Rep. 2012;39:2021–9.PubMedCrossRef
22.
Zurück zum Zitat Bao L, Yan Y, Xu C, Ji W, Shen S, Xu G, et al. Microrna-21 suppresses pten and hsulf-1 expression and promotes hepatocellular carcinoma progression through akt/erk pathways. Cancer Lett. 2013;337:226–36.PubMedCrossRef Bao L, Yan Y, Xu C, Ji W, Shen S, Xu G, et al. Microrna-21 suppresses pten and hsulf-1 expression and promotes hepatocellular carcinoma progression through akt/erk pathways. Cancer Lett. 2013;337:226–36.PubMedCrossRef
23.
Zurück zum Zitat Lin CY, Tsai PH, Kandaswami CC, Lee PP, Huang CJ, Hwang JJ, et al. Matrix metalloproteinase-9 cooperates with transcription factor snail to induce epithelial-mesenchymal transition. Cancer Sci. 2011;102:815–27.PubMedCrossRef Lin CY, Tsai PH, Kandaswami CC, Lee PP, Huang CJ, Hwang JJ, et al. Matrix metalloproteinase-9 cooperates with transcription factor snail to induce epithelial-mesenchymal transition. Cancer Sci. 2011;102:815–27.PubMedCrossRef
24.
Zurück zum Zitat Thomas MB, Jaffe D, Choti MM, Belghiti J, Curley S, Fong Y, et al. Hepatocellular carcinoma: consensus recommendations of the national cancer institute clinical trials planning meeting. J Clin Oncol : Off J Am Soc Clin Oncol. 2010;28:3994–4005.CrossRef Thomas MB, Jaffe D, Choti MM, Belghiti J, Curley S, Fong Y, et al. Hepatocellular carcinoma: consensus recommendations of the national cancer institute clinical trials planning meeting. J Clin Oncol : Off J Am Soc Clin Oncol. 2010;28:3994–4005.CrossRef
25.
Zurück zum Zitat Gordan JD, Thompson CB, Simon MC. Hif and c-myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell. 2007;12:108–13.PubMedCentralPubMedCrossRef Gordan JD, Thompson CB, Simon MC. Hif and c-myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell. 2007;12:108–13.PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat Philip B, Ito K, Moreno-Sanchez R, Ralph SJ. Hif expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression. Carcinogenesis. 2013;34:1699–707.PubMedCrossRef Philip B, Ito K, Moreno-Sanchez R, Ralph SJ. Hif expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression. Carcinogenesis. 2013;34:1699–707.PubMedCrossRef
27.
Zurück zum Zitat Dai CX, Gao Q, Qiu SJ, Ju MJ, Cai MY, Xu YF, et al. Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and myc, is a critical prognostic factor in patients with hcc after surgery. BMC Cancer. 2009;9:418.PubMedCentralPubMedCrossRef Dai CX, Gao Q, Qiu SJ, Ju MJ, Cai MY, Xu YF, et al. Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and myc, is a critical prognostic factor in patients with hcc after surgery. BMC Cancer. 2009;9:418.PubMedCentralPubMedCrossRef
28.
Zurück zum Zitat Liu H, Chen G, Zhang W, Zhu JY, Lin ZQ, Gong ZC, et al. Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential. J Cancer Res Clin Oncol. 2013;139:287–95.PubMedCrossRef Liu H, Chen G, Zhang W, Zhu JY, Lin ZQ, Gong ZC, et al. Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential. J Cancer Res Clin Oncol. 2013;139:287–95.PubMedCrossRef
29.
Zurück zum Zitat Han M, Liu M, Wang Y, Mo Z, Bi X, Liu Z, et al. Re-expression of mir-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in mcf-7 cells. Mol Cell Biochem. 2012;363:427–36.PubMedCrossRef Han M, Liu M, Wang Y, Mo Z, Bi X, Liu Z, et al. Re-expression of mir-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in mcf-7 cells. Mol Cell Biochem. 2012;363:427–36.PubMedCrossRef
30.
Zurück zum Zitat Zhang Q, Bai X, Chen W, Ma T, Hu Q, Liang C, et al. Wnt/beta-catenin signaling enhances hypoxia-induced epithelial–mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1alpha signaling. Carcinogenesis. 2013;34:962–73.PubMedCrossRef Zhang Q, Bai X, Chen W, Ma T, Hu Q, Liang C, et al. Wnt/beta-catenin signaling enhances hypoxia-induced epithelial–mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1alpha signaling. Carcinogenesis. 2013;34:962–73.PubMedCrossRef
31.
Zurück zum Zitat Peinado H, Olmeda D, Cano A. Snail, zeb and bhlh factors in tumour progression: An alliance against the epithelial phenotype? Nat Rev Cancer. 2007;7:415–28.PubMedCrossRef Peinado H, Olmeda D, Cano A. Snail, zeb and bhlh factors in tumour progression: An alliance against the epithelial phenotype? Nat Rev Cancer. 2007;7:415–28.PubMedCrossRef
32.
Zurück zum Zitat Sun D, Sun B, Liu T, Zhao X, Che N, Gu Q, et al. Slug promoted vasculogenic mimicry in hepatocellular carcinoma. J Cell Mol Med. 2013;17:1038–47.PubMedCentralPubMedCrossRef Sun D, Sun B, Liu T, Zhao X, Che N, Gu Q, et al. Slug promoted vasculogenic mimicry in hepatocellular carcinoma. J Cell Mol Med. 2013;17:1038–47.PubMedCentralPubMedCrossRef
33.
Zurück zum Zitat Zhao XL, Sun T, Che N, Sun D, Zhao N, Dong XY, et al. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial–mesenchymal transition regulator twist1. J Cell Mol Med. 2011;15:691–700.PubMedCrossRef Zhao XL, Sun T, Che N, Sun D, Zhao N, Dong XY, et al. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial–mesenchymal transition regulator twist1. J Cell Mol Med. 2011;15:691–700.PubMedCrossRef
34.
Zurück zum Zitat Hanna SC, Krishnan B, Bailey ST, Moschos SJ, Kuan PF, Shimamura T, et al. Hif1alpha and hif2alpha independently activate src to promote melanoma metastases. J Clin Invest. 2013;123:2078–93.PubMedCentralPubMedCrossRef Hanna SC, Krishnan B, Bailey ST, Moschos SJ, Kuan PF, Shimamura T, et al. Hif1alpha and hif2alpha independently activate src to promote melanoma metastases. J Clin Invest. 2013;123:2078–93.PubMedCentralPubMedCrossRef
35.
Zurück zum Zitat Chen JS, Huang XH, Wang Q, Huang JQ, Zhang LJ, Chen XL, et al. Sonic hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase/akt signaling-mediated activation of matrix metalloproteinase (mmp)-2 and mmp-9 in liver cancer. Carcinogenesis. 2013;34:10–9.PubMedCrossRef Chen JS, Huang XH, Wang Q, Huang JQ, Zhang LJ, Chen XL, et al. Sonic hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase/akt signaling-mediated activation of matrix metalloproteinase (mmp)-2 and mmp-9 in liver cancer. Carcinogenesis. 2013;34:10–9.PubMedCrossRef
Metadaten
Titel
HIFs enhance the migratory and neoplastic capacities of hepatocellular carcinoma cells by promoting EMT
verfasst von
Yang Liu
Yawei Liu
Xiaolu Yan
Yuan Xu
Fei Luo
Jing Ye
Han Yan
Xiaojun Yang
Xiaodan Huang
Jianping Zhang
Guozhong Ji
Publikationsdatum
01.08.2014
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 8/2014
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2056-0

Weitere Artikel der Ausgabe 8/2014

Tumor Biology 8/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.